EQL PHARMA AB Net Asset Quality Index

EQL PHARMA AB net asset quality index. EQL PHARMA AB (7JK) has a Net Asset Quality Index of 31.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €850.89 Million minus total liabilities of €583.83 Million yields net assets of €267.06 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check EQL PHARMA AB earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.